IMAX (IMAX) – Research Analysts’ Weekly Ratings Updates

IMAX (NYSE: IMAX) recently received a number of ratings updates from brokerages and research firms:

• 7/25/2026 – IMAX was upgraded by Wall Street Zen from “hold” to “buy”.
• 7/24/2026 – IMAX had its price target raised by Roth Capital from $48.00 to $50.00. They now have a “buy” rating on the stock.
• 7/24/2026 – IMAX had its “buy” rating reaffirmed by HC Wainwright.
• 7/24/2026 – IMAX had its price target raised by JPMorgan Chase & Co. from $47.00 to $50.00. They now have an “overweight” rating on the stock.
• 7/24/2026 – IMAX had its price target raised by Wells Fargo & Company from $41.00 to $45.00. They now have an “equal weight” rating on the stock.
• 7/24/2026 – IMAX had its price target raised by Barrington Research from $46.00 to $50.00. They now have an “outperform” rating on the stock.
• 7/24/2026 – IMAX had its price target raised by Wedbush from $46.00 to $54.00. They now have an “outperform” rating on the stock.
• 7/23/2026 – IMAX had its “neutral” rating reaffirmed by The Goldman Sachs Group, Inc.. They now have a $42.00 price target on the stock.
• 7/23/2026 – IMAX had its price target raised by Roth Capital to $48.00. They now have a “buy” rating on the stock.
• 7/20/2026 – IMAX had its price target raised by B. Riley Financial, Inc. from $48.00 to $52.00. They now have a “buy” rating on the stock.
• 7/20/2026 – IMAX had its “buy” rating reaffirmed by Rosenblatt Securities. They now have a $47.00 price target on the stock.
• 7/16/2026 – IMAX was upgraded by Weiss Ratings from “hold (c+)” to “buy (b-)”.
• 7/16/2026 – IMAX had its “equal weight” rating reaffirmed by Wells Fargo & Company. They now have a $41.00 price target on the stock, down from $47.00.
• 7/16/2026 – IMAX was downgraded by Wells Fargo & Company from “overweight” to “equal weight”. They now have a $41.00 price target on the stock.
• 7/9/2026 – IMAX was given a new $40.00 price target by The Goldman Sachs Group, Inc..
• 6/24/2026 – IMAX had its “buy” rating reaffirmed by Seaport Research Partners. They now have a $50.00 price target on the stock.
• 6/23/2026 – IMAX was downgraded by Weiss Ratings from “buy (b-)” to “hold (c+)”.
• 6/22/2026 – IMAX had its “buy” rating reaffirmed by Benchmark Co..

IMAX Corporation is a global leader in immersive entertainment technologies, specializing in the design, manufacture and distribution of high-resolution cameras, projectors, and proprietary software solutions that enhance both film production and theatrical exhibition. The company licenses its premium large-format system to theatre owners and filmmakers around the world, enabling audiences to experience movies with greater clarity, scale and sound fidelity. IMAX also offers turnkey theatre development services, assisting cinema operators with auditorium design, installation and custom branding to optimize the customer experience.

Founded in 1967 and headquartered in Mississauga, Ontario, IMAX has built a reputation for pioneering film-format innovations, including its patented dual 15-perforation, 70-millimeter projection system.